Physician profile
Mary E Ryan
NPI 1801857206
$1,999.96
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,000.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $399.60 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $312.14 | 2021 | |
| Lilly USA, LLC | $234.96 | 2021 | |
| Novo Nordisk INC | $156.96 | 2021 | |
| Amgen INC. | $119.36 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.24 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.13 | 2021 | |
| Merck Sharp & Dohme LLC | $81.61 | 2021 | |
| Pfizer INC. | $70.34 | 2021 | |
| Currax Pharmaceuticals LLC | $69.21 | 2021 | |
| Abbott Laboratories | $60.85 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $39.87 | 2021 | |
| Eisai INC. | $33.90 | 2021 | |
| Amarin Pharma, INC. | $31.10 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.02 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $25.67 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $24.48 | 2021 | |
| Esperion Therapeutics, INC. | $16.03 | 2021 | |
| Ironshore Pharmaceuticals INC. | $14.71 | 2021 | |
| Endo Pharmaceuticals INC. | $14.64 | 2021 | |
| Daiichi Sankyo INC. | $13.38 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.66 | 2021 | |
| Exeltis, USA INC. | $12.19 | 2021 | |
| Glaxosmithkline, LLC. | $12.11 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.80 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.